WMAR: FDA Raises Concerns After Inspecting Emergent BioSolutions
The FDA spent eight days inspecting Baltimore's Emergent BioSolutions plant which was set to make the Johnson & Johnson vaccine.
Posted
Copyright 2024 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
